Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quandary Medical is a private U.S. medical device company focused on advanced surgical medicine, particularly minimally invasive spine surgery. The company is closely associated with the TranS1 brand and commercializes technologies such as the AxiaLIF system for presacral access and lumbar interbody fusion, along with related spinal implants and instrumentation. Publicly available information indicates the business was formed in 2015 and acquired assets associated with TranS1 following Baxano Medical's bankruptcy process. Its product portfolio appears centered on commercial-stage spine devices and intellectual property rather than a traditional therapeutic drug pipeline. Overall, Quandary Medical looks like a small, private medtech company operating in the orthopedic/spine segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quandary Medical.